To cite this paper use one of the standards below:
This study details the synthesis and evaluation of a novel N-acylhydrazone inspired by melatonin's neuroprotective properties. Designed to target the systemic metal imbalance and copper-induced oxidative stress in Alzheimer's disease, the compound successfully mitigated metal toxicity in early testing. Supported by favorable LogP, hydrolytic stability and molecular docking profiles, it emerges as a promising dual-action therapeutic candidate.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper